contact us
Alexion Pharmaceuticals Inc (ALXN.O) said on Wednesday it would buy privately held biotech company Syntimmune for a total value of up to $1.2 billion, bolstering its portfolio of drugs to treat rare disorders.
Do Not Allow Advertisers to Use My Personal information